Framework of Intrinsic Immune Landscape of Dormant Prostate Cancer
Androgen deprivation therapy (ADT) is the standard therapy for men with advanced prostate cancer (PCa). PCa often responds to ADT and enters a dormancy period, which can be recognized clinically as a minimal residual disease. However, the majority of these patients will eventually experience a relap...
Main Authors: | Nelson K. Y. Wong, Xin Dong, Yen-Yi Lin, Hui Xue, Rebecca Wu, Dong Lin, Colin Collins, Yuzhuo Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-05-01
|
Series: | Cells |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4409/11/9/1550 |
Similar Items
-
Resistance to Antiandrogens in Prostate Cancer: Is It Inevitable, Intrinsic or Induced?
by: Norman J. Maitland
Published: (2021-01-01) -
Identification of bicalutamide resistance-related genes and prognosis prediction in patients with prostate cancer
by: Yuezheng Li, et al.
Published: (2023-04-01) -
Buccopharyngeal route administered high polyphenolic olive oil and COVID‐19: A pilot clinical trial
by: Francisco Rodríguez‐Argente, et al.
Published: (2023-10-01) -
External radiotherapy for prostate cancer with or without androgen deprivation: Geneva, 1991 to 2004
by: R Miralbell, et al.
Published: (2009-09-01) -
Tumor immune contexture predicts recurrence after prostatectomy and efficacy of androgen deprivation and immunotherapy in prostate cancer
by: Sujun Han, et al.
Published: (2023-03-01)